Low Hemoglobin Associated With Elevated Risk of CIN
CIN developed in 14.7% of patients with low hemoglobin levels compared with 5% of those with normal levels.
Contrast-Induced Nephropathy
N-Acetylcysteine May Protect Against CIN
N-acetylcysteine patients had significantly decreased odds of contrast-induced nephropathy.
Reduced Risk of Contrast-Induced Nephropathy With Iodixanol
Greatest reduction for N-acetylcysteine in patients receiving low-osmolar contrast media.
New Findings May Improve Prediction of Contrast-Induced Nephropathy
Risk is linked to small changes in serum creatinine and eGFR on the day after contrast exposure.
Central Venous Pressure-Guided Hydration May Reduce CIN
Reduced risk of contrast-induced nephropathy with no increase in acute heart failure.
Contrast-Induced Nephropathy in Kidney Tx Patients Characterized
Study reveals a 13% incidence of CIN in allograft recipients undergoing computed tomography or cardiac catheterization with contrast media.
Hydration During PCI Reduces Contrast Nephropathy
Contrast-Induced Nephropathy is significantly associated with mortality and need for dialysis; hydration is also a predictor of CIN.
Statins Promising for Cancers
Studies suggest that these cholesterol-lowering drugs can improve treatment of genitourinary cancers and prevent contrast-induced nephropathy.
Are statins a valid approach for preventing contrast-induced nephropathy (CIN)?
Patients treated with statins have a significant 55% decreased odds of contrast-induced nephropathy.
Contrast Nephropathy Associated with Long-Term Mortality in CKD
Increased long-term mortality risk for patients with, but not those without, chronic kidney disease.
Next post in Chronic Kidney Disease (CKD)
